posaconazole
posaconazole: 4 clinical trials tracked.
posaconazole evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
What is verified about posaconazole, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 3 study sponsors
Clinical Trial Registry Records (4)
A Modular Phase I/II, Open-label, Multi-Centre Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Primary endpoint: Module 1: Number of participants with dose-limiting toxicity (DLT)
A Phase II, Randomised, Open-label, Multicentre Study of Posaconazole Plus PD-1 Inhibitors and Chemotherapy Versus PD-1 Inhibitors and Chemotherapy as Neoadjuvant Therapy for Triple Negative Breast Cancer
Primary endpoint: Pathological Complete Response
A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl-2 Inhibitor BGB-11417 in Patients With Myeloid Malignancies
Primary endpoint: Part 1 And 2: Number Of Participants Experiencing Dose-limiting Toxicities (DLTs)
A Phase 1b Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine in Treatment-Naive Subjects With Acute Myelogenous Leukemia Who Are Greater Than or Equal to 60 Years of Age and Who Are Not Eligible for Standard Induction Therapy
Primary endpoint: Number of Participants Experiencing Adverse Events (AEs)